Metastasis of nasopharyngeal carcinoma to the spleen: a case report. [PDF]
Alfirm R +4 more
europepmc +1 more source
888P Comparing paclitaxel plus cisplatin versus cisplatin in concurrent chemoradiotherapy for stage IV locoregionally advanced nasopharyngeal carcinoma: A phase II randomized trial [PDF]
Liping Guo +6 more
openalex +1 more source
Abstract Background Boron neutron capture therapy (BNCT) is a treatment modality that utilises high intensity neutron beam in combination with a boron drug to target cancer cells at the cellular level. Despite decades of research in this field, there are very few reports on out‐of‐field patient dose of BNCT.
Ryo Kakino +11 more
wiley +1 more source
TP53-dependent antitumor effects of DHODH Inhibition in nasopharyngeal carcinoma. [PDF]
Dong X, Zhang Y, Zhang Z, Liu T, Gu D.
europepmc +1 more source
Determination of phosphatidylinositol-3-kinase gene copy number and protein expression in nasopharyngeal carcinoma by real-time PCR and immunohistochemistry [PDF]
Mohammad Firoozinia
openalex
Exploring the Role of Serum Uric Acid as a Potential Biomarker in Nasopharyngeal Carcinoma: A Retrospective Study Post-Adjuvant Chemotherapy [PDF]
Liang Zeng
openalex +1 more source
Facial reconstruction with implants of porous polyethylene [PDF]
Berghaus, Alexander, Myers, Eugene N.
core
ABSTRACT Epstein‐Barr virus (EBV) is a ubiquitous herpesvirus and a causal factor for Burkitt Lymphoma (BL), Hodgkin Lymphoma (HL), gastric carcinoma (GC) and nasopharyngeal carcinoma (NPC). Whether EBV contributes to a wider spectrum of cancers remains uncertain.
Marisa D. Muckian +4 more
wiley +1 more source
Radiosensitivity Enhancement by Combined Treatment of Nimotuzumab and Celecoxib on Nasopharyngeal Carcinoma Cells [Retraction]. [PDF]
europepmc +1 more source

